Files and links (1)
Accepted (AM)Open Access (License Unspecified), Open
Journal article
Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease
Expert opinion on drug discovery, v 10(1), pp 17-36
Jan 2015
PMID: 25488672
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Introduction: The endocannabinoid (eCB) system plays an important role in the control of mood, and its dysregulation has been implicated in several psychiatric disorders. Targeting the eCB system appears to represent an attractive and novel approach to the treatment of depression and other mood disorders. However, several failed clinical trials have diminished enthusiasm for the continued development of eCB-targeted therapeutics for psychiatric disorders, despite the encouraging preclinical data and promising preliminary results obtained with the synthetic cannabinoid nabilone for treating post-traumatic stress disorder.Areas covered: This review describes the eCB system's role in modulating cell signaling within the brain. There is a specific focus on eCB's regulation of monoamine neurotransmission and the stress axis, as well as how dysfunction of this interaction can contribute to the development of psychiatric disorders. Additionally, the review provides discussion on compounds and drugs that target this system and might prove to be successful for the treatment of mood-related psychiatric disorders.Expert opinion: The discovery of increasingly selective modulators of CB receptors should enable the identification of optimal therapeutic strategies. It should also maximize the likelihood of developing safe and effective treatments for debilitating psychiatric disorders.
Metrics
Details
- Title
- Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease
- Creators
- Ryan Wyrofsky - Drexel University, Department of Pharmacology and PhysiologyPaul McGonigle - Drexel UniversityElisabeth J Van Bockstaele - Drexel University, Department of Pharmacology and Physiology
- Publication Details
- Expert opinion on drug discovery, v 10(1), pp 17-36
- Publisher
- Informa UK, Ltd
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Pharmacology and Physiology
- Web of Science ID
- WOS:000346467800003
- Scopus ID
- 2-s2.0-84918801853
- Other Identifier
- 991019167625404721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Pharmacology & Pharmacy